Stem Cells Predicting Orthopedic Outcomes
Can Stem Cells Predict Orthopaedic Outcomes? The Correlation of Bone Density Findings Post Total Hip Arthoplasty With Stem Cell Assays Obtaned at Time of Surgery
1 other identifier
observational
203
1 country
1
Brief Summary
This is a pilot study to provide preliminary data of the association between bone mineral denity adjacent to acetabular implants, as measured by quanitative computed tomography (QCT), at least 2 years post Total Hip Arthoplasty (THA) surgery with Mesechymal stem cell assays, obtained at time of surgery, and to begin to evaluate if stem cells can predict orthopaedic surgical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2011
CompletedFirst Submitted
Initial submission to the registry
May 4, 2011
CompletedFirst Posted
Study publicly available on registry
June 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2014
CompletedSeptember 6, 2023
September 1, 2023
2.7 years
May 4, 2011
September 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Can Stem Cells Predict Orthopaedic Outcomes?
Bone mineral density adjacent to acetabular implants will be evaluated using QCT which can show early bony changes, which can provide information about the quality of implant fixation and surrounding bone adaption. X-rays will evaluate component loosening, wear, alignmet and osteolytis. Patient characteristics will be summarized using descriptive statistics. Spearman correlation coefficients will be used to assess the association of Mesenchymal stem cell assays and bone density findings.
Enrollment expected to begin June 2011and this pilot study is expected to be completed by May 2012.
Study Arms (1)
Stem cell & quanitative computed tomography QCT testing
The association between bone mineral denity adjacent to acetabular implants, as measured by quanitative computed tomography (QCT), at least 2 years post Total Hip Arthoplasty (THA) surgery and mesechymal stem cell assays, obtained at time of surgery, will evaluate if stem cells can predict orthopaedic surgical outcomes. Detailed Description: Subjects who have undergone a THA and who previously consented to "Stem Cell Quality Assays: Correlation with Aging/Health" study which used excess bone marrow and blood samples to complete stem cell assay labs will be invited back at least 2 years post THA to complete bilateral hip x-rays, if not already completed as part of routine medical follow up plus a QCT bone density testing and to complete a questionnaire regarding smoking, alcohol and exercise history along with recording BMIs.
Eligibility Criteria
Orthopaedic surgical patients at specific clinic
You may qualify if:
- subjects who previously had a total hip arthroplasty and had stem cell assays completed on excess bone marrow
You may not qualify if:
- Subjects who do not wish to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nebraska Medical Center, Orthopaedic Surgery
Omaha, Nebraska, 68198, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Garvin, MD
UNMC
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2011
First Posted
June 6, 2011
Study Start
April 22, 2011
Primary Completion
January 10, 2014
Study Completion
January 10, 2014
Last Updated
September 6, 2023
Record last verified: 2023-09